Surface-Activated Bone Graft
Amplify®

Amplify Standalone Synthetic Bone Graft

4
Published Clinical Studies
100%
Equivalent to Autograft
Surface Architecture
Proprietary Needle Surface Technology

Amplify® is a proprietary surface-activated bone graft comprised of scientifically and clinically studied biomaterials.

Amplify® comprises a proprietary mixture of biphasic (HA/βTCP) ceramic granules suspended in an alkylene oxide polymer carrier. The polymer carrier provides a cohesive matrix between granules that allows intra-operative molding by the surgeon and facilitates delivery to the surgical site. Amplify® can be used either standalone or in combination with autograft bone (1:1 ratio) as a bone graft extender. Amplify® is supplied in an open-barrel syringe, packaged in a blister pack that is terminally sterilized. The device is offered in sizes of X-Small (1.875 g), Small (3.75 g), Medium (7.50 g) and Large (15.0 g).

Equivalent to Autograft. Bimodal Resorption. Proprietary Surface Architecture.

Clinically Proven Performance

Demonstrated equivalency to autograft in prospective clinical trials, Amplify combines a bimodal resorption profile that nourishes healing in its earliest stages with sustained support for fusion maturation through late-stage remodeling.

Enhanced Cellular Integration

Increased surface area, porosity, and dissolution rate promote cellular attachment, proliferation, and remodeling.

Immune-Modulating

Polarizes macrophages toward the M2 phenotype.

Osteoinductive

Demonstrated in a large animal sheep model.

We enhance these granules utilizing our patented surface topography process.

These submicron needle-shaped features significantly increase surface area for bone formation and create a microenvironment that can polarize macrophages to the M2 phenotype.

Clinically Proven Biphasic Granules

The base biphasic granules used in Amplify have a well-established clinical history in spine fusion procedures and have demonstrated equivalency to autograft in peer-reviewed clinical trials.[1–4]

Cervical Fusion

Prospective
& Randomized
24 months

Equivalent
to Autograft [1]

58PATIENTS

Deformity Correction

Prospective
& Randomized
24 months

Equivalent
to Autograft [3]

341PATIENTS

Lumbar Fusion

Prospective
24 months

94% Fusion [2]

106PATIENTS

Deformity Correction

Prospective
24 months

Equivalent
to Autograft [4]

58PATIENTS

Proprietary
Polymer Carrier

Cohesive Molecular Composition

Facilitates accurate graft placement and containment at the defect site and can be readily mixed with autograft bone.

Biologically Quiet Resorption

Resorbs into surrounding tissues and is excreted from the body within 24 hours of resorption. [7,8]

Intra-operative handling

Want more information on Amplify®? Submit the quick contact form and our product specialists will get back to you right away!

What is Amplify® surface activated bone graft putty made of?

Amplify® is made of biphasic ceramic granules enhanced through Ventris’ patented surface topography process. The result is a resorbable, surface-activated synthetic bone graft designed to support bone formation at the fusion site.

Amplify® can be used standalone or combined with autograft bone at a 1:1 ratio as a bone graft extender. It is placed in either the posterolateral spine or the intervertebral disc space during spinal fusion procedures.

Amplify® is used in spinal fusion procedures. The base biphasic granules have a documented clinical history across cervical fusion, lumbar fusion, and deformity correction (scoliosis.)

Amplify® is supplied in an open-barrel syringe, sealed inside a blister pack that is terminally sterilized in its final packaging. The open-barrel design lets the surgeon deliver the product directly into the graft site without a separate delivery device, which reduces prep time and minimizes items opened on the sterile field

X-Small, Small, Medium, and Large.

The rest of the Ventris portfolio.

Backpack®

Bone Graft Fusion System

Allocell®

Family of Premium Allograft Products

Contour®

Moldable Bioactive Bone Graft

Connext®

Surgical Matrix

Cellesta®

Amniotic Membrane Allograft